Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xue-Feng He

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Bioengineered|March 2, 2021
Muscleblind-like 1 antisense RNA 1 inhibits cell proliferation, invasion, and migration of prostate cancer by sponging miR-181a-5p and regulating PTEN/PI3K/AKT/mTOR signalingXiang Ding, Xu Xu, Xue-Feng He, et al.
Journal of the American Chemical Society|January 20, 2023
Discovery of an Imine Reductase for Reductive Amination of Carbonyl Compounds with Sterically Challenging AminesFei-Fei Chen, Xue-Feng He, Xin-Xin Zhu, et al.
Zhong Yao Cai = Zhongyaocai = Journal of Chinese Medicinal Materials|March 6, 2009
[Analysis of the chemical constituents of essential oil from Magnolia biondii by GC-MS]Jin-Qing Lu, Yu-Ting Xu, Xiao-Lian Zhan, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|April 9, 2022
[The Role and Mechanism of Tfh and B Cell in Human Chronic Graft-Versus-Host-Disease]Kang-Kang Lyu, Mi-Mi Xu, Yuan-Yuan DU, et al.
Annals of Hematology|June 29, 2022
Rapid and deep response to avapritinib in heavily treated acute myeloid leukemia with t (8;21) and KIT mutationJia Yin, Feng Zhu, Zhi-Bo Zhang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|August 3, 2013
[IAG regimen for patients with refractory/relapsed acute myeloid leukemia]Yong Yang, Cheng-fu Ji, Yan-ming Zhang, et al.
Blood Advances|March 1, 2021
Low-dose decitabine for refractory prolonged isolated thrombocytopenia after HCT: a randomized multicenter trialYaqiong Tang, Jia Chen, Qifa Liu, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Bioengineered|March 2, 2021
Muscleblind-like 1 antisense RNA 1 inhibits cell proliferation, invasion, and migration of prostate cancer by sponging miR-181a-5p and regulating PTEN/PI3K/AKT/mTOR signalingXiang Ding, Xu Xu, Xue-Feng He, et al.
Journal of the American Chemical Society|January 20, 2023
Discovery of an Imine Reductase for Reductive Amination of Carbonyl Compounds with Sterically Challenging AminesFei-Fei Chen, Xue-Feng He, Xin-Xin Zhu, et al.
Zhong Yao Cai = Zhongyaocai = Journal of Chinese Medicinal Materials|March 6, 2009
[Analysis of the chemical constituents of essential oil from Magnolia biondii by GC-MS]Jin-Qing Lu, Yu-Ting Xu, Xiao-Lian Zhan, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|April 9, 2022
[The Role and Mechanism of Tfh and B Cell in Human Chronic Graft-Versus-Host-Disease]Kang-Kang Lyu, Mi-Mi Xu, Yuan-Yuan DU, et al.
Annals of Hematology|June 29, 2022
Rapid and deep response to avapritinib in heavily treated acute myeloid leukemia with t (8;21) and KIT mutationJia Yin, Feng Zhu, Zhi-Bo Zhang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|August 3, 2013
[IAG regimen for patients with refractory/relapsed acute myeloid leukemia]Yong Yang, Cheng-fu Ji, Yan-ming Zhang, et al.
Blood Advances|March 1, 2021
Low-dose decitabine for refractory prolonged isolated thrombocytopenia after HCT: a randomized multicenter trialYaqiong Tang, Jia Chen, Qifa Liu, et al.
Pageof 2